Year : 2020 | Volume
: 14 | Issue : 2 | Page : 21--34
Coronavirus disease 2019–what do we know so far?
Anirudda Pai1, Edward Hutchison1, Sali Urovi1, Maria Maccaroni1, Gyanesh Namjoshi1, Naveen Nain1, Shankari Serumadar2
1 Department of Cardiothoracic Anaesthesia, Essex Cardiothoracic Centre, United kingdom
2 Department of Haematology, Basildon Hospital, MSE University Hospitals Group, Nethermayne, Basildon SS16 5NL, United kingdom
The syndrome caused by coronavirus disease 2019 (COVID-19) has led to a wide spectrum of disease severity, and this has conferred immense pressures on hospitals worldwide, particularly within critical care. Given the rapid surge in clinical data from millions of people infected and the overwhelming scientific quest, we, the clinicians, need accurate evidence regarding the management of this disease. WHO has named this disease spectrum as COVID-2019. We seek to provide a comprehensive review of the fast-evolving literature including diagnosis, management, and novel therapies that are indicated in the management of COVID-19.
MD, DNB, FRCA, FFICM Anirudda Pai
Essex Cadiothoracic centre, Nethermayne, Basildon SS165NL
|How to cite this article:|
Pai A, Hutchison E, Urovi S, Maccaroni M, Namjoshi G, Nain N, Serumadar S. Coronavirus disease 2019–what do we know so far?.Egypt J Cardiothorac Anesth 2020;14:21-34
|How to cite this URL:|
Pai A, Hutchison E, Urovi S, Maccaroni M, Namjoshi G, Nain N, Serumadar S. Coronavirus disease 2019–what do we know so far?. Egypt J Cardiothorac Anesth [serial online] 2020 [cited 2020 Nov 25 ];14:21-34
Available from: http://www.ejca.eg.net/article.asp?issn=1687-9090;year=2020;volume=14;issue=2;spage=21;epage=34;aulast=Pai;type=0